Labtech
114 South Street, Hopkinton, MA, 01748, United States
Overview
LabTech is a global laboratorial technology company that supplies laboratory products and solutions to analytical laboratories. It is organized by functions of R&D, production, sales, and service. Major LabTech products include organic/inorganic sample preparation systems, laboratory cooling/heating/temperature control equipment, analytical instruments, laboratory information management system,s and laboratory design, and engineering, which possess a superior feature with our state-of-art techniques and manufacturing facilities. The company was founded in 2002 and is based in Hopkinton, Massachusetts.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Biotechnology
- Commercial
- Life Science
- Manufacturing
Investment portfolio
- Fever
Led · Series C · Jul 2018
Fever is a New York City-based live entertainment discovery platform with strong Spanish roots. The company curates and sells tickets for immersive and branded experiences, including Harry Potter, Stranger Things, Van Gogh, Jurassic World, Friends, and the Candlelight classical concert series. Via Candlelight, Fever has become the largest seller of live classical music in the world. Over the last year the company says it doubled its turnover and that North America now comprises over 50% of group revenues. Just over a year after a Series E that raised over $227 million at a valuation above $1 billion, Fever secured a new financing valuing it at about $1.8 billion. The new funding is aimed at doubling down on existing efforts and investing in new content opportunities. Fever is a live-entertainment discovery platform that analyses consumer data to help creators curate unique events and experiences. The platform helped organizers adapt during and after COVID by making experiences more accessible to new audiences worldwide. Fever cites revenue growth of 10x since 2019. Management and investors point to its technology, partnerships, and creator network as the basis for continued growth and expansion. The company emphasizes enabling memorable real-life (IRL) experiences despite the rise of digital ‘metaverse’ propositions. Fever was founded in 2011 by Pep Gomez and is now co-led by Ignacio Bachiller Ströhlein, Alexandre Perez Casares, and Francisco Hein. Fever’s core product is a consumer app that generates personalized event listings and feeds into its Secret Media Network, which collects anonymized user data from the company’s social media channel. That anonymized data is analyzed by Fever’s proprietary algorithms to help companies plan and create events, with examples including themed shows in Hollywood and Los Angeles and Candlelight Concerts aimed at young audiences. The company claims 25 million unique users per month across main markets in London, New York, Paris and Madrid. Fever says it differentiates from other platforms by avoiding discount-driven events and by using firsthand behavioral data to predict demand for new experiences. The startup plans to use the new funding to expand into new cities, targeting Chicago and Barcelona next and then launching new markets every couple of months, mostly in the U.S. and Europe this year and Asia next year. Fever may also collaborate with other Rakuten portfolio companies to help SMBs increase customer engagement. Fever operates an urban events discovery app alongside a branded media network (Secret Media Network and city channels such as Secret London and Secret NYC) to market events and gather community insights. It uses anonymised behavioral data and recommendation algorithms to predict untapped demand and A/B-test themed 'Fever Originals' immersive experiences across venues and cities. The company says its network reaches more than 12M unique users per week in its main markets (London, New York, Paris, Madrid), enabling large waitlists and rapid sell-outs. Fever runs a 'marketing fee' monetization strategy—no booking fees for users—charging organisers commissions tied to its ability to drive ticket sales, which it says is roughly 3–5× a traditional ticketing fee. The business reached break-even about a year ago and reports its current cities have been growing self-sufficiently at roughly 100% year‑on‑year since then. Fever plans to expand its own-brand events and enter new markets across Europe and North America. Fever was founded in June 2011 by Pep Gómez under the corporate name Kzemos Technologies, S.L. The company is listed with locality Barcelona and opened an office in New York in 2012. Fever has raised multiple rounds since 2012, including a 2012 seed via a €1M convertible, further €1M in 2013, $3M in 2014 and larger financings in 2015. In 2015 it reported €6.6M in revenue (five times 2014) and a net profit of €105,000, and the company had about 80 employees. Fever has stated plans to reach profitability for all its markets within a maximum of two months.
Team
No current team members are available.